People Can't Get Covid Boosters in Maine Because of Staffing Woes at Drugstores
(Bloomberg) -- Walgreens Boots Alliance Inc., a critical player in the U.S. vaccination campaign, has canceled some booster-shot appointments in Maine due to staffing issues, a state health official said.Â
People began reporting the issue on Twitter last week to Nirav Shah, the director of the northern New England state's Center for Disease Control and Prevention. Shah said he contacted Walgreens, thinking he could help if there was a supply shortfall.Â
Instead, the drugstore operator attributed the cancellations to staffing issues, Shah said on Thursday at a press briefing by the Association of State and Territorial Health Officials.Â
A Walgreens spokesperson said the company has adjusted its pharmacy hours in a limited number of stores to accommodate current staffing needs. Walgreens employees work with patients to reschedule any affected appointments at these stores as quickly as possible, the spokesperson added.Â
Walgreens, CVS Health Corp. and other pharmacies in the U.S. are playing an even larger role in getting Covid shots into arms than at the outset of the vaccination campaign. Initially, states hosted mass sites that could immunize thousands of people a day. Those have largely been shut down, leaving pharmacies as the most visible and accessible remaining options for many people.Â
Shah, who is also president of ASTHO, said he's heard of cancellations at pharmacies across the Northeast, from Maine to Maryland. While the issue has been reported at other pharmacies in Maine, the bulk of the reports are related to Walgreens, he said. Â
©2021 Bloomberg L.P.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.